Last Updated on January 4, 2025 by The Health Master
CDSCO
The Indian Ministry of Health and Family Welfare (MoHFW) has published a a notice regarding the requirements of different senior positions to join the to join the Central Drugs Standard Control Organisation (CDSCO).
CDSCO is actively seeking well qualified candidates to join the 14 vacant posts which include:
- 1 Additional Drugs Controller,
- 4 Joint Drugs Controllers and
- 9 Deputy Drugs Controllers.
Eligibility and key requirements:
Type of post: It is on deputation basis (including short-term contract).
Eligibility: Applicants must be currently employed with the following:
- Central Government,
- State Government,
- Union Territories,
- Research institutions,
- Public Sector Undertakings,
- Recognized universities,
- Autonomous / Statutory Organizations.
Focus of the posts on Medical Devices: All the above posts are Group ‘A’ Gazetted non-ministerial category.
Expansion of CDSCO:
This recruitment drive is a part of the expansion plan in CDSCO.
This expansion plan may includes up to 300 new positions in near future.
This plan will strengthen the regulatory framework of the medical device and pharmaceutical sectors in India.
At present staff position at CDSCO:
At present, CDSCO is working with 197 dedicated officers. These officers are posted at regional offices, subregional offices, drug testing laboratories, zonal and sub-zonal offices, and port offices.
-
What are the posts required at CDSCO?
1. Additional Drugs Controller
2. Joint Drugs Controllers
3. Deputy Drugs Controllers -
What employment type is this?
Deputation basis (including short-term contract)
-
What is the eligibility for these post?
Candidate must currently serving under the Central Government, State Government, Union Territories, Research institutions, Public Sector Undertakings, Recognized universities, Autonomous or Statutory organizations.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: This information is based on publicly available news reports and may be subject to change.
Disclaimer: This article is for informational purposes only and should not be considered legal or professional advice.
CDSCO to undergo massive Expansion in the coming year
Double Approval: New Pneumonia Drugs Get CDSCO and USFDA Nod
CDSCO approval granted to market Insulin Inhalation Powder
CDSCO directs expedited Approval of Rare Disease Drugs and Medical Devices
CDSCO approves Robotic System for Telesurgery
CDSCO Panel approval granted for Anti Cancer Drug Pertuzumab
Action on Misleading Drug Advertisements: Telangana
Key Notes on Revised Schedule M: Point No. 20 – Computerised systems
Spurious drugs seized in Telangana
Govt bans Nimesulide use in animals: A major step
Key Notes on Revised Schedule M: Point No. 19 – Good practices in quality control
US Drug Patent Expirations: A Boon for Indian Pharma
Kolkata raid: Spurious drugs worth Rs 6.6 Crore seized
Key Notes on Revised Schedule M: Point No. 18 – Good practices in production
Pharma and Cosmetics Get a Boost as India Reopens Menthol Imports
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
